Coronavirus Disease
📧 Sign up to get email alerts when something new happens for Coronavirus Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-29Clinical Trial Results: SPI-1005 Treatment in Severe COVID-19 Patients [Phase 2]
A Phase 2 trial evaluating SPI-1005 for treatment of severe COVID-19 has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: SPI-1005 Treatment in Severe COVID-19 Patients [Phase 2]
Phase 2 trial update for SPI-1005 in severe COVID-19 patients. Current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) [Phase 2, Phase 3]
Phase 2/3 trial results update for Molnupiravir (MK-4482) in non-hospitalized adults with COVID-19; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: A Study of TAK-919 in Healthy Japanese Adults (COVID-19) [Phase 1, Phase 2]
Phase 1/2 clinical trial of TAK-919 in healthy Japanese adults for COVID-19 has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 [Phase 2]
Phase 2 trial update evaluating CimetrA in patients diagnosed with COVID-19 has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-22Clinical Trial Update: Lianhua Qingwen for the Rehabilitation of Patient With Coronavirus Infection [Phase 4]
Phase 4 clinical trial update investigating Lianhua Qingwen for rehabilitation of patients with coronavirus infection.
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001) [Phase 1]
Phase 1 dose-ranging trial assessing safety and immunogenicity of V590 COVID-19 vaccine in healthy adults; terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-23Clinical Trial Update: A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001) [Phase 1, Phase 2]
Clinical trial update for V591 COVID-19 vaccine in healthy participants (Phase 1/2) terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial assessing melatonin for preventing COVID-19 in healthcare workers.
-
CLINICAL_TRIALS trial_result · 2021-11-15Clinical Trial Update: Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease [Phase 2]
Phase 2 clinical trial assessing oral lactoferrin as a safe antiviral and immunoregulatory treatment for COVID-19 and related coronavirus in…
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial [Phase 2, Phase 3]
Phase 2/3 clinical trial update for Angiotensin-(1,7) treatment in COVID-19 (ATCO Trial).
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Dipeptidyl Peptidase-4 inhibitors (e.g., linagliptin) in diabetic patients with establis…
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 [Phase 3]
Phase 3 clinical trial update for post-exposure prophylaxis/preemptive therapy targeting SARS-CoV-2; study completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus? [Phase 3]
Phase 3 trial investigating hydroxychloroquine as pre-exposure prophylaxis for healthcare workers exposed to coronavirus; study terminated.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease [Phase 3]
Phase 3 trial evaluating hydroxychloroquine for in-patients with symptomatic COVID-19; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating methotrexate with LDL-like nanoparticles (Nano-COVID19) for patients with mild COVID-19 and associated…
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study [Phase 2, Phase 3]
A randomized, single-blinded study evaluating convalescent plasma for COVID-19 (phases 2 and 3) has completed.
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: Efficacy and Safety of Favipiravir in Management of COVID-19 [Phase 3]
Phase 3 trial update reporting efficacy and safety of favipiravir in managing COVID-19.
-
CLINICAL_TRIALS trial_result · 2020-05-05Clinical Trial Update: Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19 [Phase 3]
Phase 3 clinical trial investigating levamisole and isoprinosine for immune-prophylaxis against COVID-19 in Egyptian healthcare workers; sta…
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19 [Phase 3]
Phase 3 trial exploring BCG vaccine for immune-prophylaxis in Egyptian healthcare workers during COVID-19 pandemic.
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 [Phase 3]
Phase 3 trial update on the efficacy and safety of darunavir with cobicistat for COVID-19 pneumonia.